Extrahepatic transarterial radioembolization to treat fibrolamellar hepatocellular carcinoma: A case report

[1]  S. Shrikhande,et al.  Management of fibrolamellar hepatocellular carcinoma. , 2018, Chinese Clinical Oncology.

[2]  D. Tiniakos,et al.  Fibrolamellar Hepatocellular Carcinoma: Treatment with Yttrium-90 and Subsequent Surgical Resection , 2018, CardioVascular and Interventional Radiology.

[3]  B. O'Neil,et al.  Locoregional and systemic therapy for hepatocellular carcinoma. , 2017, Journal of gastrointestinal oncology.

[4]  R. Kerlan,et al.  Safety and Efficacy of Doxorubicin Drug-Eluting Embolic Chemoembolization of Hepatocellular Carcinoma Supplied by Extrahepatic Collateral Arteries. , 2016, Journal of vascular and interventional radiology : JVIR.

[5]  W. Kassahun.  Contemporary management of fibrolamellar hepatocellular carcinoma: diagnosis, treatment, outcome, prognostic factors, and recent developments , 2016, World Journal of Surgical Oncology.

[6]  T. Pawlik,et al.  Fibrolamellar hepatocellular carcinoma: current clinical perspectives , 2015, Journal of hepatocellular carcinoma.

[7]  Justin G. Peacock,et al.  Radiotherapy for Metastatic Fibrolamellar Hepatocellular Carcinoma , 2013, Rare tumors.

[8]  T. Pawlik,et al.  A systematic review: treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma. , 2012, Journal of the American College of Surgeons.

[9]  D. Sze,et al.  Embolization of parasitized extrahepatic arteries to reestablish intrahepatic arterial supply to tumors before yttrium-90 radioembolization. , 2011, Journal of vascular and interventional radiology : JVIR.

[10]  M. D'Angelica,et al.  Outcome of patients with fibrolamellar hepatocellular carcinoma , 2006, Cancer.

[11]  M. Choti,et al.  Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium. , 2013, Gastrointestinal cancer research : GCR.